tirzepatide reston va Now Available: MOUNJARO® (tirzepatide) at THE CLINIC SUITE! We are excited to announce that FDA-approved Mounjaro, the dual-action GIP and GLP-1 receptor agonist, is now available for our patients. This innovative weekly Tirzepatide - 6 Month Plan

American Journal of Physiology-Endocrinology and Metabolism , 291 (6), E1290-E1294

You can also book your appointment online and take the next step toward feeling your best from the inside out.

of patients using Tirzepatide reported significant weight loss in the first 3 months

Participants can be healthy or have been diagnosed with a specific condition

Although much progress has been made over the last two decades, the precise cellular/molecular mechanism(s) underlying NAFLD development and progression have not been clearly defined

Scale numbers might plateau while appearance changes dramatically due to visceral fat reduction and muscle definition emerging prominently